News & Updates

High consumption of healthy plant foods and low intake of animal foods appear to reduce the risks of liver cancer and colorectal cancer (CRC), suggests a study. These associations seem partly mediated through gut microbiota and systemic metabolism.

Immunization against the human papillomavirus (HPV) can reduce the incidence of various cancer types in females 9 to 26 years of age, according to a study.

Extranodal extension (ENE) of lymph node metastases is a robust predictor of survival in head and neck squamous cell cancers (HNSCC) and appears to be independent of nutritional status, reports a study.

Several social determinants of health (SDoH) appear to influence paediatric central nervous system (CNS) tumour outcomes, suggests a study.

Combination treatment with pembrolizumab and adjuvant radiotherapy (RT) does not pose any serious risk to patients with triple-negative breast cancer (TNBC), showing no increase in radiation-related adverse events (AEs), a study has shown.

Treatment with sacituzumab tirumotecan (sac-TMT) shows a promising antitumour activity and an acceptable safety profile in patients with heavily pretreated advanced or metastatic urothelial carcinoma (UC), according to a phase II study.

New drug applications approved by US FDA as of 1-15 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.